Showing results (411-420 of 1,720) with videos related to
Sort By:
Pageof 172
Leukemia|June 1, 1996
DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cellsM Britos-Bray, N Sacchi, A D FriedmanPharmacology, Biochemistry, and Behavior|August 26, 1998
Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicityS D Friedman, E Castañeda, G K HodgeOral Surgery, Oral Medicine, and Oral Pathology|September 1, 1980
Myotonic dystrophy: report of a caseR D Friedman, J Joe, L Z BodakCancer Immunology, Immunotherapy : CII|February 4, 2025
PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progenyMohammad A Alzubi, Theresa Barberi, Alan D FriedmanBlood|November 13, 2023
How I diagnose and treat thrombocytopenia in geriatric patientsPatrick Foy, Kenneth D Friedman, Laura C MichaelisJournal of Cellular Physiology|February 1, 1992
Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cellsK Watanabe, G Lam, R S Keresztes, et al.Respiratory Medicine Case Reports|October 4, 2017
Thoracic splenosis: History is the keyTirsa M Ferrer Marrero, Valentin Prieto-Centurion, Howard A JaffeThe Journal of Clinical Endocrinology and Metabolism|April 1, 1995
The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseasesK Tordjman, A Jaffe, N Grazas, et al.The Journal of Experimental Medicine|January 1, 1986
Decay-accelerating factor is present on cultured human umbilical vein endothelial cellsA S Asch, T Kinoshita, E A Jaffe, et al.Pageof 172